UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Gilead launches new, improved hepatitis B drug
by Marian Chu
2017-05-25 10:29
Hanmi ranked No. 1 in R&D investment
by Lee Hye-seon
2017-05-24 14:19
Korean drugmakers challenge Pfizer’s smoking cessation therapy Champix
by Lee Hye-seon
2017-05-24 13:16
FDA approves 1st cancer drug for tumors with particular genetic feature
by Marian Chu
2017-05-24 12:37
Rising demand for cosmeceuticals forces pharmaceuticals to jump into cosmetics market
by Constance Williams
2017-05-24 11:35
라인
Approvals of incrementally modified drugs poured in last year
by Lee Hye-seon
2017-05-23 10:55
Ildong confident of its hepatitis drug surviving market competition
by Marian Chu
2017-05-23 10:33
Will Korea’s first stem cell therapy pass reexamination?
by Nam Doo-hyun
2017-05-22 13:43
No more calls for drug price hikes based on inaccurate statistics: MOHW
by Nam Doo-hyun
2017-05-19 15:13
Celltrion launches anti-blood cancer biosimilar in Germany
by Constance Williams
2017-05-18 17:00
라인
Hanmi wins approval for 1st asthma-rhinitis combination drug
by Constance Williams
2017-05-17 17:32
Young children of pharmaceutical firms’ owners have shares
by Nam Doo-hyun
2017-05-17 17:18
Ildong Pharmaceutical develops its first new drug
by Lee Hye-seon
2017-05-17 14:42
Sanofi, LG Chemical in court battle over Zemiglo
by Lee Hye-seon
2017-05-16 16:41
P2 trial over for GemVax’s prostate disease drug
by Marian Chu
2017-05-15 11:00
라인
‘Korean pharmaceuticals should expand US export with new drugs’
by Nam Doo-hyun
2017-05-11 17:18
Roche’s bladder cancer drug fails P3 trial
by Constance Williams
2017-05-11 16:25
Celltrion adds reason why Remsima can target US market
by Constance Williams
2017-05-11 11:50
Investors focus on Moon-related shares
by Nam Doo-hyun
2017-05-10 20:02
FDA gives accelerated approval to bladder cancer drug
by Constance Williams
2017-05-10 11:11
-
이전
121
122
123
124
125
126
127
128
129
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top